New oral fixed-dose combinations of 17-β estradiol and natural progesterone are being developed that, if approved, will offer a regulated alternative to compounded hormonal therapy for menopause symptoms.
Medscape Medical News …read more
New oral fixed-dose combinations of 17-β estradiol and natural progesterone are being developed that, if approved, will offer a regulated alternative to compounded hormonal therapy for menopause symptoms.
Medscape Medical News …read more